Profound Medical Corp.
PROF · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$7,889 | -$15,954 | -$10,724 | -$5,334 |
| Dep. & Amort. | $145 | $143 | $163 | $76 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $989 | $442 |
| Change in WC | -$3,478 | $355 | $1,250 | -$766 |
| Other Non-Cash | $1,742 | $1,386 | $39 | -$60 |
| Operating Cash Flow | -$9,480 | -$14,069 | -$8,283 | -$5,642 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $2 | $5 | -$290 | -$523 |
| Stock Issued | $0 | $0 | $0 | $39,168 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | -$2,992 |
| Financing Cash Flow | $2 | $5 | -$290 | $35,653 |
| Forex Effect | -$994 | $2,902 | $94 | -$2,222 |
| Net Chg. in Cash | -$10,472 | -$11,162 | -$8,479 | $27,789 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $35,273 | $46,435 | $54,912 | $27,123 |
| End Cash | $24,802 | $35,273 | $46,433 | $54,912 |
| Free Cash Flow | -$9,480 | -$14,069 | -$8,283 | -$5,642 |